Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts Payable And Accrued Liabilities Disclosure [Text Block] ACCRUED EXPENSES Accounts Payable Current Accounts payable Disclosure of accounting policy for accrued expenses. The entity is required to estimate expenses for which it has incurred and has not been invoiced. Accrued Expense Policy [Text Block] Accrued Expenses Accrued Liabilities Current Accrued expenses Total accrued expenses Accrued Professional Fees Current Professional fees Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated other comprehensive income Additional Paid In Capital Common Stock Additional paid-in capital Additional Payment Arrangement [Member] Additional Payment Arrangement [Member] Additional Payment Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Aggregate share-based compensation expense to be amortized. Aggregate Share Based Compensation Expense To Be Amortized Share-based compensation expense remaining to be amortized Amendment Flag Amendment Flag Anticipated merger related costs payable to third parties. Anticipated Merger Related Costs Merger related costs Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Antidilutive securities excluded from computation of earnings per share amount Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Assets Total assets Assets [Abstract] ASSETS Assets Current Total current assets Assets Current [Abstract] Current assets: Breach of termination agreement, maximum days to cure. Breach Of Termination Agreement Maximum Days To Cure Breach of termination agreement, maximum days to cure Business Acquisition Acquiree [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition Share Price Merger agreement offer to purchase issued and outstanding stock price per share Cash And Cash Equivalents At Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Cash And Cash Equivalents Fair Value Disclosure Fair value of cash and cash equivalents Cash And Cash Equivalents Period Increase Decrease Net increase (decrease) in cash and cash equivalents Cash And Cash Equivalents Policy [Text Block] Cash and Cash Equivalents Collaboration Agreements [Line Items] Collaboration Agreements [Line Items] Collaboration Agreements [Line Items] Collaboration Agreements [Table] Collaboration Agreements [Table] Collaboration Agreements [Table] Revenue generated from a collaboration research, development and commercialization agreement with a related party which include payments to us for non-refundable license fees, milestones, collaborative research and development funding, royalties and the reimbursement of contractual payments due to a third party. Collaboration Revenue Related Party Collaboration revenue - related party Collaboration revenue related to the non-exclusive license. Collaboration Revenue Related To Non Exclusive License [Member] Collaboration revenue related to the non-exclusive license Collaborative Arrangement Disclosure [Text Block] COLLABORATION Commitments And Contingencies Commitments and contingencies (Note 7) Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Line Items] Commitments And Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Table] Commitments and Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES Common Stock Par Or Stated Value Per Share Common stock, par value Common Stock Shares Authorized Common stock, shares authorized Common Stock Shares Issued Common stock, shares issued Common Stock Shares Outstanding Common stock, shares outstanding Common Stock Value Common stock, $0.001 par value; 200,000,000 shares authorized at June 30, 2014 and December 31, 2013; 151,470,155 and 134,119,350 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively Comprehensive Income Net Of Tax Comprehensive loss Comprehensive Income Net Of Tax [Abstract] Comprehensive loss: Computation Of Basic And Diluted Earnings Per Common Share [Table] Computation Of Basic And Diluted Earnings Per Common Share [Table] Computation Of Basic And Diluted Earnings Per Common Share [Table] Concentration Risk Credit Risk Concentration of Credit Risk Contingently issuable shares to a related party (including those issuable pursuant to a related party's stock subscription rights) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Contingently Issuable Shares To Related Party Excluded From Calculation Of Earnings Per Common Share Contingently issuable shares to a related party excluded from calculation of earnings per common share Cost Of Revenue Cost of revenues Costs And Expenses Total operating expenses Costs And Expenses [Abstract] Operating expenses: Current Fiscal Year End Date Current Fiscal Year End Date Deferred Revenue Noncurrent Deferred revenue The aggregate deferred revenue amount from a related party based on non-refundable payments made under the development and commercialization agreement. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. Deferred Revenue Related Party Deferred revenue, related party The carrying amount of consideration received or receivable from related parties as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year including license fees, milestone payments and royalties, but excluding interest income. Deferred Revenue Related Party Current Deferred revenue, related party The noncurrent portion of deferred revenue amount from related parties as of balance sheet date. Deferred revenue from related party is the carrying amount of consideration received or receivable as of the balance sheet date from a related party on potential earnings that were not recognized as revenue in conformity with GAAP and is not expected to be recognized in the next twelve months. Deferred Revenue Related Party Net Of Current Portion Deferred revenue, related party, net of current portion Amount of previously reported deferred or unearned revenue from a related party that was recognized as revenue during the period. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized. Deferred Revenue Related Party Revenue Recognized Deferred revenue, related party, recognized Depreciation Depreciation Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure Of Compensation Related Costs Share Based Payments [Text Block] SHARE-BASED COMPENSATION Document and entity information. Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Line Items] Document Period End Date Document Period End Date Document Type Document Type Due From Related Parties Current Receivables from related party Due From Related Parties Noncurrent Receivables from related party, net of current portion Earnings Per Share [Abstract] Earnings Per Share [Abstract] Earnings Per Share Basic And Diluted Basic and diluted net loss per common share Earnings Per Share Basic And Diluted [Abstract] Basic and diluted net loss per common share: Earnings Per Share [Text Block] NET LOSS PER COMMON SHARE Effect Of Exchange Rate On Cash And Cash Equivalents Effect of changes in exchange rates on cash and cash equivalents Employee Related Liabilities Current Payroll and benefits Entities [Table] Entities [Table] Entity Central Index Key Entity Central Index Key Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity [Domain] Entity [Domain] Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Fair Value Of Financial Instruments Policy Fair Value Measurements General And Administrative Expense General and administrative General And Administrative Expense [Member] General and administrative Gross unrealized gains (losses) in fair value. Gross Unrealized Gains Losses In Fair Value Gross unrealized gains or losses in fair value Impact on additional paid-in capital as a result of related party's stock subscription rights. Impact On Additional Paid In Capital As Result Of Related Party Stock Subscription Rights Impact on additional paid-in capital as a result of related party's stock subscription rights Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Loss before income taxes Income Statement [Abstract] Income Statement [Abstract] Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Income Statement Location [Domain] Income Tax Expense Benefit Income tax expense The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received from a related party or recorded as a receivable. Increase Decrease Deferred Revenue Related Party Deferred revenue, related party Increase Decrease In Accounts Payable Trade Accounts payable Increase Decrease In Accrued Liabilities And Other Operating Liabilities Accrued expenses and other current liabilities Increase Decrease In Due From Related Parties Receivables from related party Increase Decrease In Operating Capital [Abstract] Changes in operating assets and liabilities: Increase Decrease In Other Operating Assets Other assets Increase Decrease In Other Operating Liabilities Other liabilities Increase Decrease In Restricted Cash Release of restricted cash Intangible Assets Net Excluding Goodwill Intangible asset, net Legal Entity [Axis] Legal Entity [Axis] Liabilities Total liabilities Liabilities And Stockholders Equity Total liabilities and stockholders' equity Liabilities And Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Current Total current liabilities Liabilities Current [Abstract] Current liabilities: Liability recorded as a result of a settlement agreement with a third-party. Liability Recorded As Result Of Settlement Agreement With Third Party Liability recorded as result of settlement agreement Maturity period of highly liquid investments for classification of cash and cash equivalents. Maturity Period Of Cash And Cash Equivalents Maturity period of cash and cash equivalents Merck [Member] Merck [Member] Merck Tender Offer Proposal Minimum percentage of voting stock owned by related party to nominate for election as director at least one designee of related party according to modification of collaboration agreement. Minimum Percentage Of Voting Stock Owned By Related Party To Nominate For Election As Director At Least One Related Party Designee Minimum percentage of voting stock owned by related party to nominate for election as director at least one related party designee Minimum sales based payment potentially owed to a third - party pursuant to a settlement agreement. Minimum Sales Based Payment Potentially Owed To Third Party Pursuant To Settlement Agreement Minimum sales-based payment pursuant to settlement agreement Nature Of Operations [Line Items] Nature Of Operations [Line Items] Nature Of Operations [Line Items] Nature of Operations [Table] Nature Of Operations [Table] Nature of Operations [Table] Negotiation obligation period for parties in regards to any efforts to negotiate a future agreement between the related party and company. Negotiation Obligation Period For Parties Negotiation obligation period for parties Net Cash Provided By Used In Financing Activities Continuing Operations Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Continuing Operations [Abstract] Cash flows from financing activities: Net Cash Provided By Used In Investing Activities Continuing Operations Net cash used in investing activities Net Cash Provided By Used In Investing Activities Continuing Operations [Abstract] Cash flows from investing activities: Net Cash Provided By Used In Operating Activities Continuing Operations Net cash used in operating activities Net Cash Provided By Used In Operating Activities Continuing Operations [Abstract] Cash flows from operating activities: Net Income Loss Net loss Net loss Nonoperating Income Expense Other income, net Novartis. Novartis [Member] Novartis Novartis Non-Exclusive License to Conduct Combination Trials Novartis Non Exclusive License To Conduct Combination Trials [Member] Novartis non-exclusive license to conduct combination trials Novartis Reimbursement. Novartis Reimbursement [Member] Novartis Reimbursement Operating Income Loss Loss from operations Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] BUSINESS OVERVIEW Other Accrued Liabilities Current Other Other Assets Current Other current assets Other Assets Noncurrent Other assets Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax Foreign currency translation adjustment Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Changes in other comprehensive income: Other Liabilities Current Other current liabilities Other Liabilities Noncurrent Other long-term liabilities Other long-term liabilities Other Non Current Liabilities [Line Items] Other Non Current Liabilities [Line Items] Other Non Current Liabilities [Line Items] Other Non Current Liabilities [Table] Other Non Current Liabilities [Table] Other Non Current Liabilities [Table] Other Noncurrent Liabilities Table [Text Block] Other Long-Term Liabilities Other Operating Activities Cash Flow Statement Other Other Sundry Liabilities Noncurrent Other Ownership Percentage of Common Shares Outstanding Ownership Percentage Of Common Shares Outstanding Common stock outstanding, ownership percentage Payables And Accruals [Abstract] Payables and Accruals [Abstract] Payments To Acquire Property Plant And Equipment Purchases of property and equipment Percentage of net sales potentially owed to a third - party pursuant to a settlement agreement. Percentage Of Net Sales Potentially Owed To Third Party Pursuant To Settlement Agreement Percentage of payments made towards settlement agreement on net sales Percentage of payments to third-party based on royalties received from related party. Percentage Of Payments To Third Party Based On Royalties Received From Related Party Percentage of payments to third-party based on royalties received from related party Percentage premium to the consideration per share paid by others to which related party has right to purchase to maintain its percentage ownership of our voting stock when shares are issued. Percentage Premium To Consideration Per Share Paid By Others For Related Party To Purchase Shares Percentage premium to the consideration per share paid by others for related party to purchase shares Potential milestone payment related to a settlement agreement with a third-party. Potential Milestone Payment Related To Settlement Agreement With Third Party Potential milestone payment related to a settlement agreement with a third-party Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock, net of offering costs Proceeds From Stock Options Exercised Proceeds from exercise of common stock options Property Plant And Equipment Net Property and equipment, net Related Party [Domain] Related Party [Domain] Related Party, One [Member] Related Party One [Member] The Baupost Group, L.L.C Related Party Transaction Due From To Related Party Related party transaction, due from (to) related party Related Party Transactions [Abstract] Related Party Transactions [Abstract] Related Party Transactions By Related Party [Axis] Related Party [Axis] Carrying value as of the balance sheet date of obligations incurred through that date related to research and development costs. Such amounts may include: (1) a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocate in accounting for a business combination to in-process projects deemed to have no alternative future use. Research And Development Accrued Expense Current Research and development contract costs Noncurrent portion of the carrying value as of the balance sheet date of obligations incurred through that date related to research and development costs. Such amounts may include: (1) a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocate in accounting for a business combination to in-process projects deemed to have no alternative future use. Research And Development Accrued Expense Noncurrent Research and development contract costs Research And Development Expense Research and development Research And Development Expense [Member] Research and development Restricted Cash And Cash Equivalents At Carrying Value Restricted cash Retained Earnings Accumulated Deficit Accumulated deficit The aggregate amount of noncash adjustment for revenue that is recorded related to a related party's stock subscription rights. Revenue Adjustment For Contingently Issuable Shares Revenue adjustment for contingently issuable shares Revenue Recognition Policy [Text Block] Revenue Recognition Revenues Total revenues Revenues [Abstract] Revenues: Schedule of Accrued Liabilities [Line Items] Schedule Of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Table] Schedule Of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule Of Accrued Liabilities Table [Text Block] Component of Accrued Expenses Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Common Shares Excluded from Calculation of Basic and Diluted Net Loss per Common Share Schedule Of Computation Of Basic And Diluted Earnings Per Common Share [Line Items] Schedule Of Computation Of Basic And Diluted Earnings Per Common Share [Line Items] Schedule Of Computation Of Basic And Diluted Earnings Per Common Share [Line Items] Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Basic and Diluted Net Loss per Common Share Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Share-Based Compensation Expense Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Option Activity under Equity Incentive Plans Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Fair Value per Share and Black-Scholes Option Pricing Model with Assumptions Used for Grants Issued Schedule Of Significant Accounting Policies [Line Items] Schedule Of Significant Accounting Policies [Line Items] Schedule Of Significant Accounting Policies [Line Items] Schedule Of Significant Accounting Policies [Table] Schedule Of Significant Accounting Policies [Table] Schedule Of Significant Accounting Policies [Table] Segment [Domain] Segments [Domain] The date of expiration for the settlement agreement with a third-party related to intangible asset. Settlement Agreement Related To Intangible Asset Expiration Date Settlement agreement related to intangible asset, expiration date Settlement Liabilities Current Accrued settlement payment Noncurrent amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers. Settlement Liabilities Noncurrent Accrued settlement payment Share Based Compensation Share-based compensation expense Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Expected dividend yield Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term 1 Expected option term Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Expected volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Risk-free interest rate Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Options exercisable, at end of the period Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Exercisable at end of the period Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Weighted average fair value of options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Options outstanding, Ending Balance Options outstanding, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding [Roll Forward] Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Options outstanding, Ending Balance Options outstanding, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Weighted Average Exercise Price per Share